Gni Group Ltd. (2160) Press Release
Q2 FY2026 Financial Results Corporate Presentation
Earlier from Gni
- Consolidated Financial Results for Q2 FY2026 (IFRS)
- Notice Concerning the Completion of the Acquisition of All Shares of AYUMI Pharmaceutical Holdings KK (Conversion into a Wholly-Owned Subsidiary)
- Notice Regarding the Execution of a Loan Agreement Containing Financial Covenants
- Notice Concerning Filing of Form S-3 Registration Statement by Gyre Therapeutics